Lipogems regenerative medicine seminar by lipocast biotech uk itinerary for shared files

•

0 gefällt mir•64 views

1) The itinerary provides details of a Lipogems Regenerative Medicine Seminar taking place on May 16th at Cirencester Park, focusing on the use of Lipogems in small and large animals. 2) There will be presentations from veterinary experts on using Lipogems for canines and equines, covering the science, procedures, and case studies. 3) Attendees will have the opportunity to observe a practical demonstration of a Lipogems treatment on a live equine case in the afternoon.

Wissenschaft

Lipogems Regenerative Medicine Seminar Itinerary
Date: 16 May
Start Time:10 am Registration
End Time: 5pm Approx.
Location: Cirencester Park
Keynote Speakers & Presentation Times
10.45am to 12.30pm Dr Offer Zeira DVM PhD, Canine Lead
Presenting on the use of Lipogems in small animal, specifically for canine use, the
procedure and science behind the treatment.
Lipogems® Equine #savingchampions
Lipogems® Canine #savingyourbestfriend
10.30am – Opening Speech
Dr. Stefano Olgiati, PhD, MS, PGCert, Chairman of the Scientific
Board for Lipocast Biotech UK Ltd
An outline of how Lipogems has been translated from human to veterinary
application
14.15pm to 3pm Prof. Adrian Wilson MBBS, BSc (Hons), FRCS, FRCS (Tr &
Orth)
A highly specialised orthopaedic surgeon, who has a global reputation for his
innovative approach to knee surgery. Adrian specialises in all aspects of soft tissue
and reconstructive knee surgery including knee realignment (osteotomy) surgery
and has pioneered techniques to improve treatment for sports injuries to the knee.
Breaks and Lunch
There will be short breaks between each talk and lunch refreshments available at
1.30pm.
12.45pm to 1.30pm & 3.30pm to 5pm (practical demonstration)
Dr Tim Watson BVM&S PhD MRCVS, Equine Lead
Presentations on case-based data in equine application followed by a demonstration
of the treatment with a live equine case in the afternoon

Further Information
➢ Pre-event reading links and information can be found on the Lipogems® Equine and Canine websites or
email Lipogems Equine for further enquiries; www.lipogemsequine.com or www.lipogemscanine.com
➢ The day course can also be followed up with booking of private additional training appointments with one of
our Lead or Consultant Lipogems Veterinary Surgeons
➢ Places are limited for the day, if you would like to book any of your colleague’s please let us know asap. Light
refreshments will be provided during the day.
➢ All registered veterinary surgeon’s attendees will be accredited in the use of Lipogems
Further Reading and Viewing
Click here for the list of Lipogems® Equine accredited veterinary surgeons.
Click here to see a variety of equine case studies and success stories.
Click here to view a video where Professor Arnold Caplan (the world authority on regenerative science) talks on the
application and use of regenerative medicine in humans at the TOBI conference in June 2016.
Click here to go to our online download centre for articles, press info and research papers.
Click here to watch an interview with Dr Tim Watson
Follow Us
@LipogemsEquine
@lipogemscanine

Weitere ähnliche Inhalte

Ähnlich wie Lipogems regenerative medicine seminar by lipocast biotech uk itinerary for shared files

1 St Ismpp Eu Meeting 01.20.10

lchipper

1 St Ismpp Eu Meeting 01.20.10

lchipper

Basal implants 3

Drvivekgaur Drvivekgaur

Unveiling the Liver's Secrets: A Practical Guide to Multiparametric Ultrasound ✨ Confused by the complexities of diffuse liver disease? ‍ You're not alone! But fear not, fellow diagnosticians, for a powerful tool lies at your fingertips: multiparametric ultrasound. This book is your passport to unlocking the mysteries of the liver, offering a practical, hands-on approach to using this cutting-edge technique. Imagine: Pinpointing liver fibrosis with precision, thanks to shear wave elastography's sound wave superpowers. Visualizing subtle tissue changes invisible to the naked eye, revealing the hidden story of the liver. Confidently differentiating between various liver diseases, guiding the way to better patient care. Mastering the latest protocols and techniques, becoming a multiparametric ultrasound pro. Boosting your diagnostic accuracy and efficiency, saving valuable time and resources. This comprehensive guide, meticulously crafted for the first edition, is your ultimate companion on the journey to conquering diffuse liver disease. We'll break down the complex concepts into bite-sized, easy-to-understand pieces, using: Clear, concise explanations free from jargon. Step-by-step instructions for acquiring optimal images. High-quality illustrations and real-world case studies to bring the theory to life. Practical tips and tricks to troubleshoot challenges and refine your skills. Whether you're a seasoned sonographer or a curious resident, this book is your key to unlocking the full potential of multiparametric ultrasound. So, grab your probe, dive into the fascinating world of the liver, and elevate your diagnostic prowess to new heights!

Multiparametric Ultrasound for the Assessment of Diffuse Liver Disease, A Pra...

Lucky Gods

Aaam training courses program jkt (1 - 2 dec 2012)

Useone Thesadman

BioPlasma World Asia 2015

Justin Barin de Jesus

Los Angeles AAPI Regional Conference

Sa2014

OMA.PMR.ASM.2014

Hossein Amani

STARSurg Collaborators' Meeting September 2014 Full Programme

STARSurg

SOFAD Newsletter - Issue 1 February 2014

Vic Shao-Chih Chiang

RUMA, the Responsible Use of Medicines in Agriculture Alliance, and the Veterinary Medicines Directorate (VMD) are pleased to announce they will be holding a conference on November 3rd 2015 at the Sainsbury’s Conference Centre, Holborn, London. The conference will address four key subjects from both an animal and human medicine perspective: What do we mean by Responsible Use? What influences Responsible Use? Measuring and Monitoring Medicine use How do we communicate what we are doing Speakers and panellists will include John Blackwell – Senior Vice President of BVA Find out more about the event: http://www.ruma.org.uk/rumavmd-conference-announcement-3-november-2015-ideas-into-action/

RUMA/VMD Conference announcement: 3 November 2015 ‘Ideas into action’

British Veterinary Association

Professionals and families from across Europe will be attending the Alstrom Syndrome UK Scientific Symposium on the 6th October 2017 in Birmingham, UK. Bringing together researchers, clinicians, professionals and families to discuss rare disease research, clinical developments and an opportunity to network with like-minded professionals. The agenda for this unique event is now available and further information can be found via the ASUK website http://www.alstrom.org.uk/ASUK-conference/

Scientific Symposium Agenda published

Catherine Lewis

Curriculum Vitae KSA

Nadeem Ahmad

The International Association of Oncology is excited to announce “Asia Pacific Cancer Congress” Conference is scheduled on 03rd – 04th December 2021 in Maldives. The Organizing Committee of Oncology genially invites all the specialists, academicians, understudies and business experts in the field of Cancer medicine and Oncology from various parts of the world to take an interest in the upcoming Oncology 2021 gathering. https://www.asiapacificcancercongress.com

Asia Pacific Cancer Congress 2021

mahe1992

This highly interactive and multidisciplinary workshop is designed to increase the practical knowledge and skills critical to establishing and maintaining a successful program for the care of patients with peritoneal surface malignancies. The first day of the course will focus on a real time HIPEC surgery procedure streamed live to the conference venue, providing unique learning opportunities. National experts will share their knowledge and experience essential to creating a successful and comprehensive peritoneal malignancy program for gastrointestinal and gynecologic malignancies.

5th Annual Mid-Atlantic Peritoneal Malignancy

Inova CME

Washington Souvenir Book - AAPI Regional Conferences

Sa2014

Compendium

Dr.Ajit Kumar Varma

Total hip replacement – a patient guide

Rugveda Fracture & Orthopedic Hospital

Cancer incidence in Malawi:Time trends 1996-2015 in Book of Abstracts of the ...

College of Medicine(University of Malawi)

Lean Belly 3x.pdf

Muzammil Hussain

Ähnlich wie Lipogems regenerative medicine seminar by lipocast biotech uk itinerary for shared files (20)

1 St Ismpp Eu Meeting 01.20.10

Basal implants 3

Multiparametric Ultrasound for the Assessment of Diffuse Liver Disease, A Pra...

Aaam training courses program jkt (1 - 2 dec 2012)

BioPlasma World Asia 2015

Los Angeles AAPI Regional Conference

OMA.PMR.ASM.2014

STARSurg Collaborators' Meeting September 2014 Full Programme

SOFAD Newsletter - Issue 1 February 2014

RUMA/VMD Conference announcement: 3 November 2015 ‘Ideas into action’

Scientific Symposium Agenda published

Curriculum Vitae KSA

Asia Pacific Cancer Congress 2021

5th Annual Mid-Atlantic Peritoneal Malignancy

Washington Souvenir Book - AAPI Regional Conferences

Compendium

Total hip replacement – a patient guide

Cancer incidence in Malawi:Time trends 1996-2015 in Book of Abstracts of the ...

Lean Belly 3x.pdf

Mehr von Lipogems Equine & Lipogems Canine

Equestrian Life June 2019

Lipogems Equine & Lipogems Canine

A Selection of Lipogems Canine Case Studies v1. Pg 3. Introduction to cases Pg 4. Case 1. Gilda ~ GSD, F, 8Y, UAP, DJD Pg 8. Case 2. English Setter, M, 2Y, Old elbow fracture Pg 10. Case 3. Working collie, Bicipital tendon partial tear Pg 12. Case 4. Golden Retriever, Collateral ligaments, cruciate right stifle rupture Pg 14. Case 5. Pet Dog, Arthritic post cruciate tear Pg 16. Case 6. Torn medial meniscus Pg 17. Further links and contacts

A Selection of Lipogems Canine Case Studies v1.

Lipogems Equine & Lipogems Canine

Intra-Articular Administration of Autologous Micro-Fragmented Adipose Tissue in Dogs with Spontaneous Osteoarthritis: Safety, Feasibility, and Clinical Outcomes OFFER ZEIRA,a SIMONE SCACCIA,a LETIZIA PETTINARI,a ERICA GHEZZI,a NIMROD ASIAG,a LAURA MARTINELLI,a DANIELE ZAHIRPOUR,a MARIA P. DUMAS,a MARTIN KONAR,a DAVIDE M. LUPI,a LAURENCE FIETTE,b LUISA PASCUCCI,c LEONARDO LEONARDI,c ALISTAIR CLIFF,d GIULIO ALESSANDRI,e AUGUSTO PESSINA,f DANIELE SPAZIANTE,g MARINA ARALLAa ABSTRACT Similar to the disease affecting humans, osteoarthritis (OA) is a painful musculoskeletal condition affecting 20% of the adult canine population. Several solutions have been proposed, but the results achieved to date are far from being satisfactory. New approaches, such as intra-articular delivery of cells (including mesenchymal stromal cells), have been proposed. Among the many sources, the adipose tissue is considered very promising. We evaluated the safety, feasibility, and efficacy of a single intra-articular injection of autologous and micro-fragmented adipose tissue (MFAT) in 130 dogs with spontaneous OA. MFAT was obtained using a minimally invasive technique in a closed system and injected in the intra- and/or peri-articular space. Clinical outcomes were determined using orthopedic examination and owners’ scores for up to 6 months. In 78% of the dogs, improvement in the orthopedic score was registered 1 month after treatment and continued gradually up to 6 months when 88% of the dogs improved, 11% did not change, and 1% worsened compared with baseline. Considering the owners’ scores at 6 months, 92% of the dogs significantly improved, 6% improved only slightly, and 2% worsened compared with baseline. No local or systemic major adverse effects were recorded. The results of this study suggest that MFAT injection in dogs with OA is safe, feasible, and beneficial. The procedure is time sparing and cost-effective. Post injection cytological investigation, together with the clinical evidence, suggests a long-term pain control role of this treatment. The spontaneous OA dog model has a key role in developing successful treatments for translational medicine. STEM CELLS TRANSLATIONAL MEDICINE 2018;00:1–10

Intra-Articular Administration of Autologous Micro-Fragmented Adipose Tissue ...

Lipogems Equine & Lipogems Canine

Lipocast bitoech uk privacy and data protection policy

Lipogems Equine & Lipogems Canine

THE company behind an innovative product “that is revolutionising how vets are able to treat tendon and ligament injuries” is planning a seminar in May to showcase treatment options, techniques, the science and clinical data. Lipocast Biotech UK brought Lipogems Equine and Canine to the UK market and said the treatment had “grown exponentially” in 2017 due to success accredited veterinary surgeons are seeing in equine and canine patients. Use in international veterinary schools is adding to positive testaments of the treatment’s capability, the firm said. A database of studies is being compiled for both equine and canine patients, with Tim Watson, of Waterlane Equine Vets, Gloucestershire, leading collection of the equine data. Lipogems offers, says Lipocast, a rapid and cost-effective means of harvesting mesenchymal stromal cells (MSCs), helping vets treat tendon and ligament injuries and manage degenerative joint diseases. Lipogems harnesses, says Lipocast Biotech, the potential of pericyte cells that surround capillaries. Following tissue injury, pericytes detach from the capillaries and gradually convert into activated MSCs and begin the process of orchestrating tissue repair. The Lipogems technique delivers MSCs from pericytes in adipose tissue that are collected by liposuction, flushed and processed using gentle mechanical disruption. These MSCs understand the nature of the injury into which they are injected and then stimulate and coordinate numerous biological processes for effective healing. For equine veterinary surgeons, the procedure can be performed stable-side in 40 minutes, with no additional culture or laboratory time is required. Lipocast Biotech UK has now announced the inaugural Lipogems Regenerative Medicine Seminar will be held on 16 May in Cirencester, Gloucestershire. The seminar, which offers five CPD hours, is free of charge, and leading vets will give lectures about the future of regenerative medicine and the science behind the technology, with case-based evidence and procedure demonstrations presented. Dr Watson said: “Lipogems is an easy technique that can be performed at the patient's side and enables prompt treatment for a wide range of common orthopaedic conditions affecting horses and ponies. The results are superior to other regenerative therapies currently used.” For more details about the seminar, email lucy_wilson@lipogemsequine.com

Vet Times February Issue 2018

Lipogems Equine & Lipogems Canine

Lipogems Equine Featured in Polo Times February 2018 Issue

Lipogems Equine & Lipogems Canine

Lipocast Biotech UK Lipogems Equine and Canine Presentation 2017 v.1.2 - With...

Lipogems Equine & Lipogems Canine

Lipocast Biotech UK Lipogems Canine Standard Operating Procedure v1

Lipogems Equine & Lipogems Canine

Lipocast Biotech UK Lipogems Equine Standard Operating Procedure 007 - withou...

Lipogems Equine & Lipogems Canine

The Effect of Intra-articular Injection of Autologous Microfragmented Fat Tissue on Proteogly can Synthesis in Patients with Knee Osteoarthritis Damir Hudetz 1,2,3,*, Igor Borić 1,4,5, Eduard Rod 1, Željko Jeleč 1, Andrej Radić 1, Trpimir Vrdoljak 1,2, Andrea Skelin 1,6, Gordan Lauc 6,7, A prospective, non-randomized, interventional, single-center, open-label clinical trial was conducted from January 2016 to April 2017 Results The results of our study indicate that the use of autologous and micro-fragmented adipose tissue in patients with knee OA (measured by dGEMRIC MRI) increased glycosaminoglycan (GAG) content in hyaline cartilage, which is in line with observed VAS and clinical results.

The Effect of Intra-articular Injection of Autologous Microfragmented Fat Tis...

Lipogems Equine & Lipogems Canine

Minimal Criteria for Defining MSC's. The ISCT Position Statement

Lipogems Equine & Lipogems Canine

Mammalian MSC from Selected Species: Features and Applications Christiane Uder, Sandra Br€uckner, Sandra Winkler, Hans-Michael Tautenhahn,†‡ Bruno Christ†* Mesenchymal stromal/stem cells (MSC) are promising candidates for cellular therapy of different diseases in humans and in animals. Following the guidelines of the International Society for Cell Therapy, human MSC may be identified by expression of a specific panel of cell surface markers (CD1051, CD731, CD901, CD34-, CD14-, or CD11b-, CD79- or CD19-, HLA-DR-). In addition, multiple differentiation potential into at least the osteogenic, adipogenic, and chondrogenic lineage is a main criterion for MSC definition. Human MSC and MSC of a variety of mammals isolated from different tissues meet these criteria. In addition to the abovementioned, they express many more cell surface markers. Yet, these are not uniquely expressed by MSC. The gross phenotypic appearance like marker expression and differentiation potential is similar albeit not identical for MSC from different tissues and species. Similarly, MSC may feature different biological characteristics depending on the tissue source and the isolation and culture procedures. Their versatile biological qualities comprising immunomodulatory, anti-inflammatory, and proregenerative capacities rely largely on the migratory and secretory capabilities of MSC. They are attracted to sites of tissue lesion and secrete factors to promote self-repair of the injured tissue. This is a big perspective for clinical MSC applications in both veterinary and human medicine. Phase I/II clinical trials have been initiated to assess safety and feasibility of MSC therapies in acute and chronic disease settings. Yet, since the mode of MSC action in a specific disease environment is still unknown at large, it is mandatory to unravel the response of MSC from a given source onto a specific disease environment in suitable animal models prior to clinical applications.

Mammalian MSC from Selected Species: Features and Applications Christiane Ude...

Lipogems Equine & Lipogems Canine

Adipose Tissue and Mesenchymal Stem Cells: State of the Art and Lipogems® Technology Development Carlo Tremolada1 & Valeria Colombo1 & Carlo Ventura2 Abstract Inthepastfewyears,interestinadiposetissueasan ideal source of mesenchymal stem cells (MSCs) has increased. These cells are multipotent and may differentiate in vitro into several cellular lineages, such as adipocytes, chondrocytes, osteoblasts, and myoblasts. In addition, they secrete many bioactive molecules and thus are considered Bmini-drugstores.^ MSCs are being used increasingly for many clinical applications, such as orthopedic, plastic, and reconstructive surgery. Adipose-derived MSCs are routinely obtained enzymatically from fat lipoaspirate as SVF and/or may undergo prolonged ex vivo expansion, with significant senescence and a decrease in multipotency, leading to unsatisfactory clinicalresults.Moreover, these techniquesare hampered by complex regulatory issues. Therefore, an innovative technique (Lipogems®; Lipogems International SpA, Milan, Italy) was developed to obtain microfragmented adipose tissue with an intact stromal vascular niche and MSCs with a high regenerative capacity. The Lipogems® technology, patented in 2010 and clinically available since 2013, is an easyto-use system designed to harvest, process, and inject refined fat tissue and is characterized by optimal handling ability and a great regenerative potential based on adipose-derived MSCs. In this novel technology, the adipose tissue is washed, emulsified, and rinsed and adipose cluster dimensions gradually are reduced to about 0.3 to 0.8 mm. In the resulting Lipogems® product, pericytes are retained within an intact stromal vascular niche and are ready to interact with the recipient tissue after transplantation, thereby becoming MSCs and starting the regenerative process. Lipogems® has been used in more than 7000 patients worldwide in aesthetic medicineandsurgery,aswellasinorthopedicandgeneralsurgery, with remarkable and promising results and seemingly no drawbacks. Now, several clinical trials are under way to supporttheinitialencouragingoutcomes.Lipogems®technology is emerging as a valid intraoperative system to obtain an optimal final product that may be used immediately for regenerative purposes.

Adipose Tissue and Mesenchymal Stem Cells: State of the Art and Lipogems® Tec...

Lipogems Equine & Lipogems Canine

Angiogenic and anti-inflammatory properties of micro-fragmented fat tissue and its derived mesenchymal stromal cells Valentina Ceserani1†, Anna Ferri1*†, Angiola Berenzi2, Anna Benetti2, Emilio Ciusani3, Luisa Pascucci4, Cinzia Bazzucchi4, Valentina Coccè5, Arianna Bonomi5, Augusto Pessina5, Erica Ghezzi6, Offer Zeira6, Piero Ceccarelli4, Silvia Versari7, Carlo Tremolada7 and Giulio Alessandri1 Background: Adipose-derived mesenchymal stromal cells (Ad-MSCs) are a promising tool for advanced cell-based therapies. They are routinely obtained enzymatically from fat lipoaspirate (LP) as SVF, and may undergo prolonged ex vivo expansion, with significant senescence and decline in multipotency. Besides, these techniques have complex regulatory issues, thus incurring in the compelling requirements of GMP guidelines. Hence, availability of a minimally manipulated, autologous adipose tissue would have remarkable biomedical and clinical relevance. For this reason, a new device, named Lipogems® (LG), has been developed. This ready-to-use adipose tissue cell derivate has been shown to have in vivo efficacy upon transplantation for ischemic and inflammatory diseases. To broaden our knowledge, we here investigated the angiogenic and anti-inflammatory properties of LG and its derived MSC (LG-MSCs) population.

Angiogenic and anti-inflammatory properties of micro-fragmented fat tissue an...

Lipogems Equine & Lipogems Canine

IFATS Presentation by Dr offer Zeira - 2016 20.11.16

Lipogems Equine & Lipogems Canine

Lipocast Biotech UK Lipogems Equine and Canine Presentation 2017 v.1.2

Lipogems Equine & Lipogems Canine

Veterinary Record - Lipogems story - Regenerative therapy for canine joint co...

Lipogems Equine & Lipogems Canine

Vet Times 2017 Lipogems Canine Feature - Novel regeneration therapy available...

Lipogems Equine & Lipogems Canine

Vet Practice News January 2017 - News Story

Lipogems Equine & Lipogems Canine

Polo Times August 2017 - Saving Champions Feature

Lipogems Equine & Lipogems Canine

Mehr von Lipogems Equine & Lipogems Canine (20)